MedPath

Cefaly US Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:7

Trial Phases

2 Phases

Phase 1:1
Not Applicable:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (83.3%)
Phase 1
1 (16.7%)

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

Recruiting
Conditions
Pregnancy
Migraine
Headache
Postpartum
Depression
Anxiety
First Posted Date
2025-01-23
Last Posted Date
2025-01-23
Lead Sponsor
Cefaly Technology
Target Recruit Count
550
Registration Number
NCT06788977
Locations
🇺🇸

https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true, Darien, Connecticut, United States

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

Not Applicable
Completed
Conditions
Migraine
First Posted Date
2018-03-14
Last Posted Date
2024-12-11
Lead Sponsor
Cefaly Technology
Target Recruit Count
607
Registration Number
NCT03465904
Locations
🇺🇸

Clinical Research Consortium, Las Vegas, Nevada, United States

🇺🇸

Pharmacology Research Institute, Encino, California, United States

🇺🇸

Yale University, New Haven, Connecticut, United States

and more 6 locations

Abortive Treatment of Migraine With the Cefaly® Abortive Program Device

Not Applicable
Completed
Conditions
Migraine
First Posted Date
2017-07-14
Last Posted Date
2018-08-07
Lead Sponsor
Cefaly Technology
Target Recruit Count
59
Registration Number
NCT03217968
Locations
🇺🇸

Rochester Clinical Research, Inc., Rochester, New York, United States

Retrospective Study on the Use of CEFALY® Device During Migraine Attacks

Completed
Conditions
Migraine
First Posted Date
2015-11-30
Last Posted Date
2017-05-08
Lead Sponsor
Cefaly Technology
Target Recruit Count
807
Registration Number
NCT02616978

Acute Treatment of Migraine With e-TNS

Not Applicable
Completed
Conditions
Migraine
First Posted Date
2015-10-29
Last Posted Date
2018-06-06
Lead Sponsor
Cefaly Technology
Target Recruit Count
106
Registration Number
NCT02590939
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

🇺🇸

Rowe Neurology Institute, Lenexa, Kansas, United States

🇺🇸

Columbia University Medical Center, New York, New York, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.